Target intelligence / Profile preview

Pneumococcal surface adhesin A (PsaA)

Target
PsaA
Molecular classification
Lipoprotein, Bacterial adhesin, ABC transporter substrate-binding protein, Other
01

Overview

Pneumococcal surface adhesin A (PsaA) is a highly conserved, surface-exposed 37-kilodalton lipoprotein found on all known serotypes of Streptococcus pneumoniae. It serves a dual role as both a high-affinity substrate-binding protein for the PsaABC ATP-binding cassette (ABC) transporter system, which is essential for manganese (Mn2+) acquisition, and as a key bacterial adhesin that mediates attachment to host nasopharyngeal epithelial cells. Manganese transport via PsaA is critical for pneumococcal growth, resistance to oxidative stress, and overall virulence. As an adhesin, PsaA interacts with host cell receptors such as E-cadherin and Annexin A2 (ANXA2) to facilitate colonization of the upper respiratory tract. Because of its high conservation across serotypes and strong immunogenicity, PsaA is a prominent target for the development of serotype-independent, protein-based pneumococcal vaccines, such as PnuBioVax, which aim to elicit protective antibodies that block colonization and prevent invasive pneumococcal diseases like pneumonia, meningitis, and otitis media.

Other names
Manganese ABC transporter substrate-binding lipoprotein PsaAPneumococcal surface antigen AManganese-binding lipoprotein PsaAMtsAPsaA protein
02

Mechanism of action

Active immunization to elicit protective antibodies that block bacterial adhesion and manganese transport, thereby preventing colonization and infection.

03

Biological functions

Cell adhesionMetal ion transportManganese importZinc bindingImmune responseOther
04

Disease associations

InfectionPneumoniaMeningitisSepsisOtitis mediaOther
05

Safety considerations

Injection site reactions (pain, tenderness)Systemic reactions (headache, fever)Potential for serotype replacement or incomplete protection if used as a monovalent vaccineLimited efficacy against invasive disease compared to colonization
06

Interacting drugs

1 more in the full profile.

07

Biomarkers

Anti-PsaA IgG antibody titerAnti-PsaA IgA antibody titer

Beyond the preview

Go deeper on Pneumococcal surface adhesin A (PsaA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pneumococcal surface adhesin A (PsaA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call